Market Overview:
The global albumin excipient market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for vaccines and other pharmaceutical products. Albumin is used as an excipient in vaccines and other pharmaceutical products due to its properties such as high purity, biocompatibility, and low immunogenicity. In addition, albumin is also used as a culture medium ingredient owing to its ability to support the growth of microorganisms. North America dominates the global albumin excipient market followed by Europe and Asia Pacific.
Product Definition:
Albumin Excipient is the term used for albumin in pharmaceutical formulations. Albumin is a protein that is found in blood and other body fluids. It is important because it helps to transport nutrients and oxygen around the body, and helps to regulate blood pressure. Albumin can also be used as an excipient in pharmaceuticals because it helps to stabilize drugs and improve their absorption.
Human Serum Albumin:
Human serum albumin is a protein that occurs naturally in the human body. It is also known as alpha-1 antitrypsin protein. It helps to protect the lungs and heart from damage caused by emphysema or cardiomyopathy conditions. Human serum albumin acts as an immunoglobulin in the human body, binding itself to certain foreign substances like drugs, toxins or pollutants present within the human blood stream which prevents their absorption by cells and tissues.
Bovine Serum Albumin:
Bovine serum albumin is a protein that occurs naturally in the human body. It is also commercially available as a product under various brand names including BSA, Albu-1, and Albu-2. The product has high usage rates in the pharmaceutical industry owing to its several properties such as thermal stability, binding characteristics with anionic surfactants for stabilizing emulsions and preventing foaming during processing of Pharmaceuticals & Biopharmaceuticals products among others.
Application Insights:
Based on the application, the global albumin excipient market is segmented into vaccine ingredient, culture medium ingredient and other ingredients. Vaccine ingredients held the largest share in 2017 due to extensive usage of human serum albumin as a vaccine carrier. The use of human-serum-albumin as a carrier for vaccines developed after its approval for this purpose under EUAs.
The U.S., India and China are estimated to account for highest consumption of HSA in vaccines owing to increasing healthcare expenditure levels coupled with growing population projected to boost demand over the forecast period. Culture medium is another important application segment owing to extensive usage of bovine serum albumin during culturing process in laboratories across different industries such as biopharmaceuticals, diagnostics and clinical research among others.
Regional Analysis:
North America accounted for the largest share of over 40.0% in 2017. The region is expected to maintain its dominance during the forecast period on account of rising product demand from various application sectors, such as vaccine ingredient and culture medium ingredient, coupled with stringent regulatory framework pertaining to drug manufacturing practices in U.S., Canada, and Mexico.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to increasing product consumption in countries like China and India due to rising healthcare expenditure by governments along with growing awareness about albumin-based products among patients & physicians especially after launch of biosimilar products in these countries which are manufactured using human serum albumin as a excipient ingredient.
Growth Factors:
- Increasing demand for albumin excipient in the biopharmaceutical and pharmaceutical industries due to its properties such as high purity, stability, and low immunogenicity.
- Growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases that require regular administration of drugs for treatment is expected to drive the demand for albumin excipient over the forecast period.
- Rising investments by key players in research and development activities to develop novel albumin excipients is anticipated to propel market growth during the forecast period.
- Technological advancements in manufacturing processes of albumin excipient are projected to provide new opportunities for market growth over the next decade.
Scope Of The Report
Report Attributes
Report Details
Report Title
Albumin Excipient Market Research Report
By Type
Human Serum Albumin, Bovine Serum Albumin
By Application
Vaccine Ingredient, Culture Medium Ingredient, Other
By Companies
CSL, Grifols, Shire (Baxalta), Octapharma, Hualan Bio, CBPO, RAAS, Kedrion, Merck, LFB Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
165
Number of Tables & Figures
116
Customization Available
Yes, the report can be customized as per your need.
Global Albumin Excipient Market Report Segments:
The global Albumin Excipient market is segmented on the basis of:
Types
Human Serum Albumin, Bovine Serum Albumin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Vaccine Ingredient, Culture Medium Ingredient, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CSL
- Grifols
- Shire (Baxalta)
- Octapharma
- Hualan Bio
- CBPO
- RAAS
- Kedrion
- Merck
- LFB Group
Highlights of The Albumin Excipient Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Human Serum Albumin
- Bovine Serum Albumin
- By Application:
- Vaccine Ingredient
- Culture Medium Ingredient
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Albumin Excipient Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Albumin excipient is a substance that is used to increase the stability of albumin.
Some of the key players operating in the albumin excipient market are CSL, Grifols, Shire (Baxalta), Octapharma, Hualan Bio, CBPO, RAAS, Kedrion, Merck, LFB Group.
The albumin excipient market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Albumin Excipient Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Albumin Excipient Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Albumin Excipient Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Albumin Excipient Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Albumin Excipient Market Size & Forecast, 2020-2028
4.5.1 Albumin Excipient Market Size and Y-o-Y Growth
4.5.2 Albumin Excipient Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Human Serum Albumin
5.2.2 Bovine Serum Albumin
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Vaccine Ingredient
6.2.2 Culture Medium Ingredient
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Albumin Excipient Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Albumin Excipient Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Human Serum Albumin
9.6.2 Bovine Serum Albumin
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Vaccine Ingredient
9.10.2 Culture Medium Ingredient
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Human Serum Albumin
10.6.2 Bovine Serum Albumin
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Vaccine Ingredient
10.10.2 Culture Medium Ingredient
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Human Serum Albumin
11.6.2 Bovine Serum Albumin
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Vaccine Ingredient
11.10.2 Culture Medium Ingredient
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Human Serum Albumin
12.6.2 Bovine Serum Albumin
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Vaccine Ingredient
12.10.2 Culture Medium Ingredient
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Human Serum Albumin
13.6.2 Bovine Serum Albumin
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Vaccine Ingredient
13.10.2 Culture Medium Ingredient
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Albumin Excipient Market: Competitive Dashboard
14.2 Global Albumin Excipient Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 CSL
14.3.2 Grifols
14.3.3 Shire (Baxalta)
14.3.4 Octapharma
14.3.5 Hualan Bio
14.3.6 CBPO
14.3.7 RAAS
14.3.8 Kedrion
14.3.9 Merck
14.3.10 LFB Group
